1.. INTRODUCTION {#S1}
================

Inflammation in the reproductive organs and peritoneum of egg-layers is a recurrent problem in commercial egg-layer flocks causing egg production drop, increased mortality and consequential economical losses and lowered animal welfare \[[@R4], [@R21]\]. Avian pathogenic *Escherichia coli* is often isolated from these lesions, but, several studies have demonstrated *Gallibacterium anatis* to be a frequent cause of oophoritis, salpingitis and peritonitis, either alone or as a co-pathogen \[[@R13], [@R25], [@R28], [@R29]\]. Moreover, *G*. *anatis* has been isolated from avian cases of septicaemia, hepatitis, enteritis and upper respiratory tract lesions \[[@R15], [@R17], [@R24], [@R25], [@R28]\]. *G*. *anatis* is a common part of the normal flora of both the upper respiratory tract and lower genital tract of chickens and other avian species \[[@R6]\], and can therefore be regarded as an opportunistic pathogen. Its pathogenesis has not been studied in depth, particularly not at the molecular level, and little is known about the genes and mechanisms behind *G*. *anatis*' ability to cause disease. The activity of extracellular proteases and the ability to degrade of chicken IgG have been suggested to be involved \[[@R12]\], as has the products of a capsule biosynthesis locus \[[@R7]\]. *G*. *anatis* is divided into two biovars: the β-haemolytic biovar *haemolytica* and the non-haemolytic biovar anatis. The ability to lyse red blood cells is a prominent phenotype of pathogenic *G*. *anatis* isolates \[[@R9]\], and the produced haemolysin is a likely virulence factor. *Gallibacterium* is a Gram-negative genus belonging to the γ-proteobacterial family *Pasteurellaceae* \[[@R9]\], and various pathogenic members of *Pasteurellaceae*, e.g. the cause of periodontal disease in humans, *Aggregatibacter actinomycemcomitans*, the causative agent of bovine shipping fever *Mannheimia haemolytica*, and the swine pathogen *Actinobacillus pleuropneumoniae* produce haemolysins and leukotoxins belonging to the group of RTX-toxins (repeat in toxin). The RTX-toxins are important virulence factors and strains lacking these genes have reduced virulence \[[@R19], [@R39], [@R40]\]. A homologous toxin, HlyA, is produced by certain extra-intestinal strains of *E*. *coli* and has been the model toxin of this group. These pore-forming RTX cytotoxins share a number of common structural features. They are large (\> 100 kDa), secreted proteins, containing varying numbers of nine amino acid (aa) glycine- and aspartate-rich calcium-binding repeats, and calcium is required for function. The proteins are exported by specific type-I secretion system (T1SS), most often encoded in the same transcriptional unit as the toxin \[[@R11]\]. A likewise co-transcribed acyltransferase posttranslationally adds acyl-groups to specific lysine residues in the toxin \[[@R37]\], these acyl-groups are essential for toxin function. The aim of this study was to examine *G*. *anatis* biovar *haemolytica*'s interactions with eukaryotic cells and to identify and characterize the genes and proteins responsible for the haemolytic phenotype. We found *G*. *anatis* to be highly cytotoxic towards avian macrophages, a trait likely to play a key role in pathogenesis. Furthermore, we identified and characterised a new type of RTX-toxin responsible for the leukotoxic and haemolytic activity in *G*. *anatis* biovar *haemolytica*.

2.. MATERIALS AND METHODS {#S2}
=========================

2.1.. Bacterial strains and growth conditions {#S3}
---------------------------------------------

*G*. *anatis* biovar *haemolytica* strain 12656-12 Liver (referred to as 12656-12) was used in this study, this strain was originally isolated from the liver of a septicaemic chicken \[[@R5]\]. *G*. *anatis* 12656-12 was grown at 37 °C either on brain heart infusion (BHI) (Oxoid, Basingstoke, UK) agar supplemented with 5% citrated bovine blood in a closed plastic bag, or in BHI broth with aeration. Anaerogen (Oxoid) was used to produce anaerobic conditions in incubator jars. *E*. *coli* strains were grown in Luria--Bertani broth and agar, the medium was supplemented with 50 μg/mL kanamycin and 20 μg/mL chloramphenicol when appropriate. All chemicals were purchased from Sigma-Aldrich (St. Louis, USA).

2.2.. Bioinformatics analyses {#S4}
-----------------------------

A draft version (115 contigs) of the genome sequence of *G*. *anatis* biovar *haemolytica* 12656-12 Liver[1](#FN2){ref-type="fn"} was obtained from 454 Life Sciences (Branford, USA), using the pyrosequencing-based method \[[@R27]\]. Gene annotation was performed using Wasabi, a web-based annotation system for prokaryotic organisms provided by the Victorian Bioinfomatics Consortium, Monash University, Australia \[[@R8]\]. Sequence similarity searches were performed using BLASTP \[[@R1]\] (databases: non-redundant protein sequences (GenBank) and SwissProt), FASTA \[[@R30]\] and SSEARCH (databases: UniProtKB and SwissProt), and HHpred \[[@R36]\] (database: Interpro, 2009). All searches were performed in March 2009. Transterm \[[@R23]\] was used to predict transcriptional terminators.

2.3.. Haemolysis assay {#S5}
----------------------

The haemolytic activity was assayed as previously described \[[@R33]\]; bovine blood was washed repeatedly in TN Buffer (10 mM Tris-HCl, 0.9% NaCl, pH 7.5) until the upper phase appeared colourless. A 2% (vol/vol) erythrocyte solution was prepared in TN-buffer supplemented with 10 mM CaCl~2~. Erythrocytes were incubated with filter-sterilised bacterial culture supernatant or bacteria in a 1:1 ratio at 37 °C for 1 h unless otherwise noted. Un-lysed erythrocytes and cell debris were collected by centrifugation and the amount of released haemoglobin was measured in a plate reader at 540 nm. 100% lysis was determined with 1% triton-X and background lysis was subtracted before calculation of haemolytic activity. The effect of heat was examined by incubating the supernatant at 60 °C for 30 min before the haemolysis assay. The effect of proteinase K was examined by incubating the supernatant with 4 μg/mL proteinase K at 37 °C for 30 min before haemolysis assay.

2.4.. Culturing of HD11 cells and lactate dehydrogenase (LDH) cytotoxicity assay {#S6}
--------------------------------------------------------------------------------

The macrophage-like cell line HD11 derived from MC29 transformation of chicken bone marrow cells \[[@R3]\] was maintained in Roswell Park Memorial Institute (RPMI) 1640 medium + GlutaMAX^TM^-I + 25 mM HEPES (Gibco, Carlsbad, USA). The media was supplemented with 2.5% chicken serum, 7.5% foetal bovine serum (FBS), and 25 μg/mL gentamicin. The cells were cultured as an adherent cell line at 37 °C with an atmosphere of 5% CO~2~ and were sub-cultured every 2nd or 3rd day. For the cytotoxicity assays the cells were seeded in 96 well plates with 2 × 10^4^ cells in RPMI added 5% FBS in a total volume of 100 μL. The cells were incubated overnight, and the media was changed. Ten μL filter-sterilised culture supernatant or bacteria resuspended in saline (0.9% NaCl) was added to the cells and incubated for 1 h. For *E*. *coli*, expression of recombinant proteins were induced as described in [Section 2.7](#S9){ref-type="sec"} and the OD~600~ (optical density at 600 nm) was adjusted to 1 corresponding to approximately 6 × 10^8^ CFU/mL. *G*. *anatis* cells and supernatant was harvested in late exponential phase (OD~600~ = 1). The suspension of *G*. *anatis* was adjusted to OD~600~ of 1 corresponding to approximately 4 × 10^8^ CFU/mL. Filter-sterilised culture supernatant was stored on ice and added to cells within 30 min after harvest. Cytotoxicity was determined with LDH cytotoxicity assay (Promega, Madison, USA) as described by the manufacturer. Each sample was assayed in triplicate wells and the experiments were repeated a minimum of three times.

2.5.. Construction of a *G*. *anatis gtxA* mutant {#S7}
-------------------------------------------------

A 1 509 bp fragment consisting of nucleotides 140 to 1648 of *gtxA* was PCR-amplified with primers 4240 and 4242, and a 1 484 bp fragment consisting of nucleotides 3995 to 5478 was amplified with primers 4243 and 4245 (primer sequences are listed in Tab. I). The two fragments were digested with restriction enzymes and ligated into the corresponding restriction sites in plasmid pWSK129 \[[@R42]\]. The gel-purified kanamycin-cassette (Tn903) from *Eco*RI-digested pUC4-KISS \[[@R2]\] was ligated into the *Eco*RI site between the two PCR-fragments. The kanamycin resistance gene was inserted in the same transcriptional direction as *gtxA*. The plasmid DNA was linearised by digestion with *Xho*I and *Sal*I and column purified. The natural competence of *G*. *anatis* 12656-12[2](#FN3){ref-type="fn"} was induced by the MIV-method as previously described for *Haemophilus influenzae* \[[@R31]\]; *G*. *anatis* was grown in BHI to an OD~600~ of 0.2, washed once in MIV and incubated in MIV for 100 min. The linear DNA was added to the cells at a concentration of 0.5 μg DNA/mL. After 20 min, two volumes of BHI were added and the bacteria were incubated for 1 h before transformants were selected on blood agar plates with 5 μg/mL kanamycin. Colonies were re-streaked and the deletion was verified with primer pairs 39F + kanR, kanF + 5334R and 2871F + 3270R. The strain was designated ΔgtxA.Table I.Primer list. Primers used for construction and verification of *gtxA* mutants. Restriction sites are underlined.Primer namePrimer sequence (5′-3′)4240TATC[GTCGAC]{.ul}TATCCATCGCGGCATCAG4242AGCT[GAATTC]{.ul}AAGCAAGTGCTATTGCTACCG4243AGCT[GAATTC]{.ul}TTATGTCGGCGATCAAACAA4245TATG[TCTAGA]{.ul}GGCGTTGGTGGATAAGAGATkanRCGATAGATTGTCGCACCTGAkanFTATGGAACTGCCTCGGTGA39FTGATGCAATCAAAGATAAAGTCG5734RAATCGGCATTGGAGCTTTC2871FAACCAAACCAATCCAAGGT3270RATTGCCGTCTTTGCCTACTG

2.6.. Construction of expression plasmids {#S8}
-----------------------------------------

Plasmids encoding full-length GtxA, the N-terminal domain of GtxA (amino acids 1--949 (Nterm)) and the RTX-domain of GtxA (amino acids 931--2026 (RTX)) with (+C) and without GtxC were constructed by the ligation of PCR-fragments into the expression vector pET28a (Novagen, EMD Biosciences, San Diego, USA). The PCR-fragments were amplified with pfx50 polymerase (Invitrogen, Carlsbad, USA), column purified, double digested with *NcoI* and *XhoI* and either column purified again or gel purified (fragments \> 6 kb). The primers used for each construct are listed in Table II. The construct Nterm+C, nucleotides 1--2847 of *gtxA* in operon with *gtxC*, was made by the use of splicing by overlap extension \[[@R18]\], where the primers GtxUP-NcoI and gtxC-r-XhoI were used in the second round of PCR. Plasmid pET28a was double digested with *NcoI* and *XhoI*, dephosphorylated with Antarctic phosphatase (New England Biolabs, Ipswich, USA) and gel purified. Vector and PCR-fragments were ligated at a molar ratio of 1:3, transformed into chemically competent *E*. *coli* Top10F′ (Invitrogen) and selected on LB-agar plates with kanamycin. The sequence of the insert in each plasmid was verified by DNA-sequencing (Macrogen, Seoul, Korea). The plasmids were transformed into the *E*. *coli* expression strain ER2566 (New England Biolabs). Plasmid pLG575 encodes *E*. *coli hlyB* and *hlyD*, components of the T1SS secreting HlyA \[[@R26]\], and was introduced to promote secretion of the expressed proteins.Table II.Primer list. Primers used for constructs for expression in *E*. *coli*. Restriction sites are underlined. Bold indicates overlapping regions for splicing by overlap extension.Primer namePrimer sequence (5′-3′)ConstructPrimers usedGtxUP-NcoIAGTC[CCATGG]{.ul}GTCTTTCATTAAAAGAAAAAGTAACTGGAATA*gtxA*+CGtxUP-NcoI & *gtxC*-r-XhoI*gtxC*-r-XhoICAGT[CTCGAG]{.ul}TTATGAATTTTCTTCTATAAAAGCAGC*gtxA*GtxUP-NcoI & *gtxA*-r-XhoI*gtxA* Cf NcoIAGTC[CCATGG]{.ul}CAATTGAATCTTTCAATTTAATCGCAARTX+C*gtxA* Cf NcoI & *gtxC*-r-XhoI*gtxA*-Nr-XhoICAGT[CTCGAG]{.ul}TTAATTTAGGAAATCGGTCATTATGCCATRTX*gtxA* Cf NcoI & *gtxA*-r-XhoI*gtxA*-r-XhoICAGT[CTCGAG]{.ul}TTAAACAAGATACATAGTGACCAGTTCATNterm+CGtxUP-NcoI & SOErev1SOErev1**GTTATCCATAATAATTAA**TTTAGGAAATCGGTCATTATGSOEfor2 & *gtxC*-r-XhoISOEfor2**TTCCTAAATTAATTAT**GGATAACTTCTCAACTTTAGGNtermGtxUP-NcoI & *gtxA*-Nr-XhoI

2.7.. Expression of recombinant GtxA proteins in *E*. *coli* {#S9}
------------------------------------------------------------

Protein expression was induced on agar plates containing 0.1 mM IPTG incubated at 30 °C. For induction in broth, an overnight culture was diluted 1:50 and incubated at 37 °C with shaking until the culture reached an OD~600~ of 0.6. Then, IPTG (0.2 mM) was added and induction was maintained for 2 h at 30 °C. To release recombinant protein from the cells, cells were pelleted by centrifugation, resuspended in 0.1 M Tris/0.9% NaCl in 1/25 of the original volume, lysed by bead beating (FastPrep) for 45 s and spun down at 4 °C, and the supernatant was used immediately for liquid haemolysis assays and LDH cytotoxicity assay.

2.8.. SDS-PAGE and Western blot analysis {#S10}
----------------------------------------

Total cellular protein was obtained by harvesting 500 μL of culture and resuspending the cell pellets in 10 mM Tris, 500 μL/ per OD unit at the time of harvest. Extracellular proteins were prepared from filter-sterilised culture supernatant (low protein binding filter (0.22 μm) (Millex^®^ GP, Millipore, Billerica, USA). Proteins were precipitated overnight by the addition of one volume ice-cold 96% ethanol, collected by centrifugation (13 000 *g* for 30 min at 0 °C), and resuspended in 10 mM Tris (1/100 of the original volume). Proteins were separated by SDS-PAGE in NuPAGE^®^ Novex gels (Invitrogen). For Western blot analysis, proteins were transferred to polyvinylidene difluoride membranes (Invitrogen). The primary antibody, rabbit antiserum raised against ApxI from *A*. *pleuropneumoniae* \[[@R35]\], was used at a 1:1333 dilution and detected with Westernbreeze Chemiluminiscent Western Blot Immunodetection Kit (Invitrogen) as described by the manufacturer.

2.9.. RNA purification {#S11}
----------------------

An overnight culture was diluted 1:100 in BHI and incubated at 37 °C with aeration. Cells were harvested at OD~600~ 0.17, 0.6, 2, 3, as well as 1 h after growth had stopped and after 24 h of incubation. Total RNA was isolated with RNeasy protect Mini Kit (Qiagen, Hilden, Germany), on-column DNAse treatment was performed as described by the manufacturer (Qiagen).

2.10.. Northern blotting {#S12}
------------------------

Blotting of RNA, probe labelling (with \[α-^32^P\]-dCTP) and hybridization was performed basically as described \[[@R10]\]. A 388 bp fragment within the RTX-half of *gtxA* was PCR-amplified with primers 3487F 5′-GCCTCTACCGCCGTTTCTG-3′ and 3874R 5′-GGCTGGCTAATAATTCATCACCTTG-3′ and used as template in the probe labelling reaction.

2.11.. Nucleotide sequence accession number {#S13}
-------------------------------------------

The sequence corresponding to *G*. *anatis gtxA* and *gtxC* has been deposited in GenBank under accession number FJ917356.

3.. RESULTS {#S14}
===========

3.1.. Cytolytic activity of *G*. *anatis* {#S15}
-----------------------------------------

*G*. *anatis* biovar *haemolytica* is β-haemolytic on bovine-blood agar plates \[[@R9]\]. To test the target range we examined the haemolysis of strain 12656-12 on agar plates with blood from different species, and the bacterium produced clear zones of β-haemolysis when grown on agar plates containing horse, cow, swine or chicken blood (data not shown), confirming the broad target range reported by Greenham and Hill \[[@R14]\]. The bacterium was haemolytic under both aerobic and anaerobic culture conditions (data not shown).

This haemolytic activity has been suggested to originate from a secreted haemolysin \[[@R14]\]. To test this, liquid haemolysis assays were performed, where *G*. *anatis* 12656-12 cell-free culture supernatants, harvested in different phases of growth, were incubated with a suspension of bovine erythrocytes and the amount of released haemoglobin measured. *G*. *anatis* supernatant from mid to late exponential phase lysed the erythrocytes efficiently (Fig. 1A). This activity was inactivated by heat (60 °C) and proteinase K, and was reduced by the calcium chelater EGTA (data not shown), confirming that *G*. *anatis* produces a calcium-dependent secreted haemolytic protein.Figure 1.Haemolytic activity of *G*. *anatis* culture supernatants and expression of GtxA. (A) Growth and haemolytic activity of cell-free culture supernatant of *G*. *anatis* 12656-12. An overnight culture was diluted 1:100 and growth (cell density measured by absorbance at 600 nm) and haemolytic activity (HA) in cell-free culture supernatant were recorded. The haemolytic activity of supernatant diluted 100-fold in BHI is shown. Extracellular proteins for Western blotting (Fig. 1B) were harvested in parallel. The experiment was repeated three times, the level of haemolytic activity varied but the relative pattern was consistent. (B) Levels of GtxA determined by Western blotting with ApxI-antiserum. Supernatants were harvested at the indicated time points, concentrated 100-fold as described in Materials and Methods and separated by SDS-PAGE in a 3--8% gel prior to blotting. Extracellular proteins from ΔgtxA were harvested at OD~600~ = 2 (lane marked ΔgtxA). WC = whole cell lysate from wild-type, the cells were harvested 5 h after inoculation. Size markers are indicated on the left. The experiment was repeated with the same result.

The lysis of erythrocytes may play a role in iron acquisition in the host, however, interactions with other types of cell, e.g. leukocytes, may play a more important role during natural infection. We therefore tested *G*. *anatis*' cytotoxic activity towards leukocytes using the avian-derived macrophage-like cell line HD11. The HD11 cells showed rounding and detached from the surface after exposure to *G*. *anatis* (Fig. 2B). The cytotoxicity was quantified using the LDH cytotoxicity assay, which showed a pronounced cell death (Fig. 2C). This leukotoxic activity of *G*. *anatis* is likely to be essential in the pathogenesis of this bacterium and proteins responsible for the leukotoxic activity are thus expected to be important virulence factors.Figure 2.Haemolytic activity and cytotoxicity of *G*. *anatis* 12656-12 wild-type (wt) and the isogenic *gtxA* mutant (ΔgtxA). (A) β-haemolysis. The bacteria were streaked on BHI-agar plates with 5% bovine blood and incubated at 37 °C for 18 h. (B) Light microscopy (100 × magnifications) of HD11 cells after 1 h incubation with saline (mock), wt or ΔgtxA. Bacteria were harvested in late exponential phase (OD~600~ = 1) and added at an m.o.i. of 10. (C) Cytotoxicity quantified with LDH activity. HD11 cells were incubated with bacteria as described in 1B. The averages of three replicate wells are shown, bars represent the S.E.

3.2.. Identification of an RTX-toxin in *G*. *anatis*' genome sequence {#S16}
----------------------------------------------------------------------

To identify a specific protein responsible for *G*. *anatis*' cytotoxic phenotype, we obtained the genome sequence of *G*. *anatis* 12656-12 and searched for sequences encoding possible toxins. Proteins belonging the group of pore-forming RTX-toxins are important virulence factors and responsible for haemolytic and leukotoxic activity in bacteria related to *Gallibacterium* \[[@R11]\], making proteins of this type an obvious target to search for. BLAST searches with the amino acid sequences of different RTX-toxins (including ApxI and ApxII from *A*. *pleuropneumoniae*, LtxA from *A*. *aggregatibacter* and HlyA from *E*. *coli*) against the *G*. *anatis* 12656-12 genome sequence led to the identification of a putative *G*. *anatis* RTX-toxin of 2026 amino acids. The 6081 nucleotide (nt) open reading frame (ORF) encoding this protein was named *gtxA*: *gtx* for *Gallibacterium* toxin and A by analogy to the designation of toxin gene in other RTX operons \[[@R11]\]. *gtxA* is followed by a very short five nucleotides (nt) intergenic region and a 492 nt ORF (Fig. 3A) encoding a predicted protein of 163 amino acids. This protein has homology to acyltransferase proteins, which are required for activation of RTX-toxins, and showed 38% identity and 60% similarity to the acyltransferease HlyC from *E*. *coli*. By analogy, the gene was named g*txC*. A rho-independent transcriptional terminator was found downstream of *gtxC* and probably marks the end of a transcriptional unit including both *gtxA* and *gtxC*. The genes flanking the *gtxA-C* operon were predicted to encode an inositol-1-monophosphatase (*suhB* upstream of *gtxA*), and a mannoate dehydratase gene (*uxuA* downstream of *gtxC*) (Fig. 3A), both of which are unlikely to be involved in GtxAC function.Figure 3.(A) The genetic organisation of *gtxA*, *gtxC* and their flanking genes in *G*. *anatis* 12656-12. Arrows indicate ORF. A predicted transcriptional terminator is indicated downstream of *gtxC*. (B) Organisation of GtxA. K indicates conserved lysine residues (Lys1484 and Lys1607). The glycine aspartate-rich region (position 1640--1830) is marked. (C) Alignment of the 15 repeats in the N-terminal domain of GtxA, the alignment was generated with Radar \[[@R16]\]. Numbers to the left indicate amino acid position in GtxA. Positions where the amino acid are identical (black) or similar (grey) in more than 50% of the repeats are marked.

Interestingly, GtxA (2026 aa) is twice as large as the "typical" RTX-toxins (approximately 1000 aa \[[@R11]\]) described from other members of the *Pasteurellaceae* family and HlyA from *E*. *coli*. The 1000 amino acids at the C-terminus of GtxA are homologous to these RTX-toxins, with whom the region shares approximately 20% sequence identity and 35% sequence similarity. This C-terminal region also contains several of the conserved features of RTX-toxins. HlyA from *E*. *coli* is acylated at Lys564 and Lys690 \[[@R37]\]; both these lysine and the preceding glycine residues are conserved in GtxA (Lys1484 and Lys1607 (Fig. 3B)), so these are likely acylation sites in GtxA mediated by GtxC. Downstream of the predicted acylation sites (aa 1640--1830), GtxA has a glycine and aspartate-rich region, which is also a conserved feature of the RTX-toxins.

In contrast, the N-terminal region (aa 1 to approximately 950) had limited similarity to available sequences, and no significant homologues were found by BLASTP searches against the GenBank database. However, the region from aa 520 to 879 had similarity (E-value 0.007) to a conserved domain (COG1511) of unknown function from predicted membrane proteins. Compared to the RTX-domain, the N-terminal domain is less acidic and contains a larger proportion of hydrophobic amino acids, particularly serine. The secondary structure was predicted to consist primarily of alpha-helices.

To get an idea of the function of the N-terminal domain, we performed a bioinformatic analysis of its amino acid sequence by the use of more sensitive search tools for sequence similarity and homology prediction. Homology searches using FASTA and SSearch found sequence similarity to the eukaryotic cytoskeletal proteins Talin-A and Talin-B from the amoeba *Dictyostelium discoide* (E-value 3.4 × 10^−7^ and 0.0061, respectively), and Talin from chickens (*Gallus gallus*) (E-value 0.0087). Furthermore, the homology detection server HHpred predicted homology to talin (probability = 100%). Talin binds to a range of other proteins, including actin, vinculin and the cytosolic part of integrins. Large proteins often consists of repeats arisen by duplications and examination of the N-terminal domain with the repeat finder Radar \[[@R16]\], found 15 repeats of 57 amino acids (Fig. 3C).

GtxA thus consists of two domains: an N-terminal repeat domain and a C-terminal RTX/cytolysin domain.

3.3.. GtxA has cytolytic activity which is dependent on GtxC {#S17}
------------------------------------------------------------

To examine if GtxA is a cytolytic protein, *gtxA* was cloned together with the predicted acyltransferase gene, *gtxC*, and introduced into the non-haemolytic expression strain *E*. *coli* ER2566. Upon expression of *gtxA* and *gtxC*, this strain exhibited a haemolytic phenotype on blood agar plates and in liquid haemolytic assays (Fig. 4), showing that GtxAC holds haemolytic activity. RTX-toxins are usually extracellular proteins exported by specific T1SS. Introduction of a plasmid (pLG575) expressing the T1SS encoded by *E*. *coli hlyBD* increased the haemolysis zone (Fig. 4A) and immunoblotting showed that a larger fraction of GtxA was present in the extracellular protein fraction (Fig. 5), demonstrating that the *E*. *coli* secretion system can secrete *G*. *anatis* GtxA. The cytotoxic activity of GtxA towards HD11 cells was assayed by LDH release assay and *E*. *coli* ER2566 expressing *gtxAC* was toxic to HD11 cells. *E*. *coli* containing vector with no insert (negative control) showed no toxicity after 1 h incubation (Fig. 4B).Figure 4.Cytotoxic activity of *E*. *coli* expressing GtxA. (A) β-haemolytic activity of *E*. *coli* ER2566 grown on LB-agar with 5% bovine blood and 0.1 mM IPTG, incubated at 30 °C. T1SS: + or − indicates the presence or absence of plasmid pLG575 which expresses the *E*. *coli* T1SS-components HlyB and HlyD. RTX = amino acids 931--2026 of GtxA, N-term = amino acids 1--949 of GtxA. (B) Liquid haemolysis assay and LDH cytotoxicity assay with *E*. *coli* ER2566/pLG575 expressing different versions of GtxA. Figure 5.Expression of GtxA in *E*. *coli*. Western blot on whole cell lysate (WC) and extracellular protein (EC) from *E*. *coli* ER2566/pLG575 after induction with IPTG. Proteins were separated by SDS-PAGE in a 4--12% gel and blotted on a PVDF-membrane. The blot was probed with ApxI-antiserum. B = blank, -T1SS indicates the absence of plasmid pLG575. Size markers are indicated on the right (PageRuler Prestained Protein Ladder Plus, Fermentas, Burlington, Canada). The upper band in each lane has the expected size of full-length GtxA (215 kDa) or the RTX-domain (117 kDa). The smaller sized bands are likely degradation products.

The requirement of post translational acylation is one of the hallmarks of RTX-toxins. To assess whether this was also the case for the atypical GtxA, we examined the activity of GtxA expressed without its predicted acyltransferase GtxC. Figure 4 shows that when GtxA was expressed in the absence of GtxC it had no cytolytic activity against erythrocytes or leukocytes. Thus, the non-acylated protoxin is inactive, and posttranslational acylation is essential for both its haemolytic and leukotoxic activities. The secretion of GtxA was not hindered by the lack of acylation, as the non-acylated GtxA was detected in the culture supernatant in amounts similar to the acylated toxin (Fig. 5).

3.4.. GtxA is responsible for *G*. *anatis*' cytotoxic activity {#S18}
---------------------------------------------------------------

To determine whether *G*. *anatis*' haemolytic and leukotoxic activity originated from GtxA, we constructed a *gtxA* knock-out mutant. No molecular tools for genetic manipulation of *Gallibacterium* had previously been described, but, we found that *G*. *anatis* 12656-12 is naturally competent[3](#FN4){ref-type="fn"}, a trait we exploited in the construction of stable *gtxA* mutants by natural transformation. In the resulting mutants, the 2347 nucleotides between positions 1648 and 3995 in *gtxA* were deleted and replaced by a kanamycin resistance cassette.

In contrast to the wild-type, the ΔgtxA mutant was not haemolytic on blood agar plates (Fig. 2A) or in liquid haemolysis assay (data not shown). Furthermore, ΔgtxA showed no cytotoxicity towards HD11 cells (Figs. 2B and 2C). Identical results were obtained from two independently constructed *gtxA* mutants. Thus, *gtxA* is responsible for the haemolytic and leukotoxic activity of *G*. *anatis*.

3.5.. Growth phase dependent levels of GtxA and its activity {#S19}
------------------------------------------------------------

The haemolytic activity of *G*. *anatis* supernatant was growth phase dependent: the activity peaked in late exponential phase, dropped at the transition to stationary phase, and was low in the supernatant from overnight cultures (Fig. 1A). This prompted us to hypothesize that the expression of GtxA was similarly growth phase dependent. To examine this and to establish GtxA's localisation, we determined the amount of GtxA in the culture supernatant (extracellular proteins) and whole cell lysates at different times throughout growth using immunoblotting with ApxI-antiserum (Fig. 1B). The ApxI-antiserum recognised several proteins in the extracellular protein fraction including a band corresponding to the size of the predicted molecular mass of full-length GtxA (215 kDa). This band was absent in ΔgtxA, supporting that the band is GtxA. Like the haemolytic activity, the presence and amounts of GtxA in the supernatant were growth phase dependent (Fig. 1B): the amount of GtxA peaked at the transition to stationary phase, and the protein was not detected in day-old cultures (24 h) which is similar to the pattern reported for *A*. *pleuropneumoniae* ApxI and ApxII \[[@R20]\] and *M*. *haemolytica* LktA \[[@R38]\]. A second band (\> 215 kDa) was also present in wild-type but absent in ΔgtxA suggesting that GtxA may exist in two different forms, possibly due to post translational modifications. Two further bands (65 kDa and \> 215 kDa, respectively) were detected in both wild-type and mutant and are likely not related to GtxA. No protein of the size of GtxA was detected in whole cell lysates at any time point, consistent with the predicted extracellular localisation and in support of GtxA being secreted immediately after or in connection with synthesis. To examine transcription of *gtxA*, Northern blotting was performed with RNA from cells harvested throughout the growth phase. The blots showed *gtxA* to be transcribed during exponential growth and in the beginning of stationary phase, but no transcript was detected 2 h into stationary phase and in overnight cultures (data not shown), indicating the transcription of *gtxA* was shut down during stationary phase. In conclusion, GtxA is expressed during in vitro growth, it is a growth phase dependent extracellular protein and the growth phase dependence is influenced by transcriptional regulation, and the balance between accumulation of secreted GtxA and its subsequent degradation.

3.6.. The N-terminal domain of GtxA is required for full cytolytic activity {#S20}
---------------------------------------------------------------------------

The bioinformatical analysis showed that GtxA has an atypical organisation compared to other pore-forming RTX-toxins consisting of two parts, an RTX-domain and an N-terminal domain (Fig. 3B). To examine the contribution of the N-terminal domain to the cytolytic activity of GtxA, both the N-terminal domain (amino acids 1--949) and the RTX-domain (amino acids 931--2026) were expressed separately in *E*. *coli* and their haemolytic and leukotoxic activities examined and compared to those of the full-length protein (Fig. 4). *E*. *coli* expressing the RTX-domain together with GtxC showed haemolytic activity on blood agar plates and in liquid haemolysis assays, thus, the RTX-domain is a functional haemolytic protein by itself and the N-terminal domain is not essential for the lysis of red blood cells. However, the RTX-domain did exhibit a markedly lower haemolytic activity than the whole toxin, indicating that the N-terminal domain is required for the full haemolytic activity. No cytotoxic activity was detected from interactions between the RTX-domain and HD11 cells suggesting that the N-terminal domain plays an essential role for leukotoxicity. Immunoblotting (Fig. 5) showed that the RTX-domain was expressed and exported; therefore the differences in activity were not due to major differences in expression levels.

*E*. *coli* expressing only the N-terminal domain had no haemolytic or cytotoxic activity (Fig. 4). However, SDS-PAGE showed that this recombinant protein was primarily present in whole cell fraction and only in diminutive amounts in the extracellular protein fraction (data not shown). We therefore tested the activity of lysates (generated by FastPrep bead beating or lysozyme/sonication treatment) of cells expressing the N-terminal domain, and these did not show any activity of the in liquid haemolysis assays or towards avian macrophages, despite prolonged incubation. These results indicate that the N-terminal domain has no cytolytic activity by itself.

4.. DISCUSSION {#S21}
==============

In this study, we report the first identification and characterisation of a specific virulence factor in *Gallibacterium*, named GtxA. GtxA is a new type of RTX-toxin and is responsible for *G*. *anatis*' leukotoxic and haemolytic activity. GtxA shares sequence similarity with RTX-toxins from related members of *Pasteurellaceae* and the α-haemolysin HlyA from *E*. *coli*. Interestingly, GtxA deviates from these toxins and the group of pore-forming RTX-toxins in general because it contains an extra 950 amino acid N-terminal domain. We demonstrated that GtxA's RTX-domain retained haemolytic activity in the absence of the N-terminal domain, confirming that it constitutes a functional unit by itself. The N-terminal domain was, however, required for full haemolytic activity of the toxin, and appeared essential for its leukotoxic activity (Fig. 4), suggesting a synergistic effect of the two domains.

The modular organisation of GtxA resembles the organisation of the adenylate cyclase toxin, CyaA, from *Bordetella pertussis*, which consists of two functional parts; an N-terminal adenylate cyclase domain and a C-terminal RTX-haemolysin domain \[[@R41]\]. However, GtxA's N-terminal domain has no homology to the adenylate cyclase domain of CyaA, or any other type of RTX-toxin. The RTX-haemolysin domain of CyaA binds to integrin (CD11b/CD18) on the target cell, inserts into the membrane and forms a pore through which the adenylate cyclase domain is transported into the cytoplasm of the target cell. Once inside the target cell, the adenylate cyclase domain catalyzes the conversion of ATP to cyclic AMP (cAMP), a key secondary messenger. The increase in cAMP concentration affects signal transduction in the host cell \[[@R41]\]. The CyaA RTX-haemolysin domain also has pore-forming (haemolytic) activity on its own \[[@R34]\] similar to the RTX-domain of GtxA. We hypothesize that GtxA employs a similar mode of action, where the RTX-haemolysin domain is responsible for binding to target cells and the translocation of either the N-terminal domain alone or the whole toxin into the cytoplasm of the target cell. Both the predicted presence of sequence repeats (Fig. 3C) and the homology to eukaryotic cytoskeletal protein talin suggest a role for the N-terminal of GtxA in protein binding. We propose that the N-terminal domain of GtxA is involved in protein-protein interactions with intracellular host cell proteins, the cytoskeletal proteins actin and vinculin are potential candidates. The binding to cytoskeletal proteins may lead to direct morphological changes and interfere with signal transduction within the cell.

The genetic organisation of the *gtxA* locus differed from the canonical RTX-toxin operon structure which comprises 4 genes in the order *rtxC*, *rtxA*, *rtxB*, *rtxD*. The 4 genes encode an acyltransferase, the structural toxin, an ABC transporter protein, and an export channel protein, respectively. The two latter are components of a T1SS and are required for the secretion of the toxin. In *G*. *anatis* 12656-12, the acyltransferase gene (*gtxC*) was positioned downstream of *gtxA*, and a secretion system was not encoded adjacent to *gtxA* or *gtxC*. GtxA was exclusively detected in the extracellular protein fraction (Fig. 1B), and the *E*. *coli* T1SS facilitated export of GtxA (Fig. 5), therefore, *G*. *anatis* is likely to encode a T1SS responsible for the export of GtxA. The lack of a co-transcribed T1SS has also been described for ApxIIA from *A*. *pleuropneumoniae*, this protein is exported via a genetically unlinked T1SS, which also secretes ApxIA \[[@R32]\]. A BLAST search in the genome sequence of *G*. *anatis* 12656-12 with the *E*. *coli* secretion system components HlyB and HlyD as queries, identified three different predicted T1SS-encoding operons (data not shown). Two of these T1SS-operons additionally included each their gene encoding putative extracellular metalloproteases, which are likely to be their substrate proteins. The third T1SS-operon did not include any predicted substrate-encoding genes, and our preliminary data indicate that GtxA is secreted by this T1SS.

In *G*. *anatis* 12656-12, a single toxin, GtxA, is responsible for both the haemolytic and leukotoxic activity. Most *A*. *pleuropneumoniae* serotypes produce more than 1 of the 3 RTX-toxins ApxI, ApxII and ApxIII \[[@R22], [@R35]\], but this is seemingly not the case with *G*. *anatis* 12656-12. Genome searches supported this notion, as no other predicted proteins with homology to the pore-forming RTX-toxins were identified. However, the genome of 12656-12 did encode two large extracellular metalloproteases containing RTX-repeats.

Our characterisation of GtxA adds further variation to the theme of bacterial toxins in general and RTX-toxins in particular. GtxA contains a new type of domain and apparently uses yet undescribed mechanisms during the interaction with host cells and in the battle against the host immune system. We expect GtxA to be essential in the pathogenesis of *G*. *anatis*, and aim for further insight into the role of this toxin in the promotion of disease.
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